Phloretin


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1026 CDKN1A Increases expression PMID:34896434
133308 SLC9B2 Decreases activity PMID:18000046
1956 EGFR Decreases expression PMID:34896434
207 AKT1 Decreases expression PMID:34896434
2099 ESR1 Increases activity PMID:9751507
2100 ESR2 Increases activity PMID:9751507
2475 MTOR Decreases expression PMID:34896434
2932 GSK3B Decreases activity PMID:16968061
366 AQP9 Decreases activity PMID:21259319; PMID:9733774
4057 LTF Increases expression PMID:24487097
4846 NOS3 Decreases expression PMID:20021702
54575 UGT1A10 Decreases activity PMID:35868516
54576 UGT1A8 Decreases activity PMID:35868516
54577 UGT1A7 Decreases activity PMID:35868516
54578 UGT1A6 Decreases activity PMID:35868516
54600 UGT1A9 Decreases activity PMID:35868516
54658 UGT1A1 Decreases activity PMID:35868516
54659 UGT1A3 Decreases activity PMID:35868516
6513 SLC2A1 Decreases activity PMID:14642735
6514 SLC2A2 Decreases expression PMID:26616219
6548 SLC9A1 Decreases activity PMID:12765964
7157 TP53 Increases expression PMID:34896434
7363 UGT2B4 Decreases activity PMID:35868516
7364 UGT2B7 Decreases activity PMID:35868516
7366 UGT2B15 Decreases activity PMID:35868516
7367 UGT2B17 Decreases activity PMID:35868516
7422 VEGFA Decreases expression PMID:34896434
842 CASP9 Decreases expression PMID:34896434

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.